Medicalgorithmics will fulfil an additional order worth almost PLN 1.5 million for a longstanding Canadian partner that provides at-home Holter electrocardiogram (ECG) tests. This is the partner’s second additional order in 2026, after an equipment order worth USD 500,000 in April.
By Editorial Team. English adaptation of the Polish original published on 12 November 2026 at 20:00 UTC.
Dr Kris Siemionow, CEO of Medicalgorithmics
The company linked the order to the partner’s rapid expansion in Canada following its acquisition by a large healthcare business listed on the New York Stock Exchange. The Canadian company specialises in organising Holter ECG tests, which monitor a patient’s heart rhythm over an extended period, at home.
“The second additional order this year from our Canadian partner is a very important signal for us. It shows that, following the change of ownership, the partner is steadily expanding its operations and is choosing our technology as it does so,” said Dr Kris Siemionow, CEO of Medicalgorithmics.
“I am proud that we can support its continued growth and be part of its success in the Canadian market. Most importantly, however, there are individual patients behind every additional device, and our solutions can save the lives of even more patients in Canada.”
Expansion follows acquisition by a US diagnostics company
According to Medicalgorithmics, its technology supports patient-centred care and provides fast, accurate test results. The Canadian partner was acquired last year by one of the leading US diagnostics companies, which is listed in New York and is pursuing rapid expansion in Canada.
The current order is part of that expansion. An earlier agreement, signed in early December, covered additional devices and an extension of the licence to use Medicalgorithmics’ software. The first additional order of this year followed in April.
